Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Search Results (47)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.Academic Article Why?
Current management strategies for peritoneal mesothelioma.Academic Article Why?
Current trends in the management of malignant peritoneal mesothelioma.Academic Article Why?
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy.Academic Article Why?
Peritoneal mesothelioma: the site of origin matters.Academic Article Why?
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis.Academic Article Why?
Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival.Academic Article Why?
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma.Academic Article Why?
The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma.Academic Article Why?
The Challenge of Defining Treatment Standards for a Rare Disease: Malignant Peritoneal Mesothelioma.Academic Article Why?
A rare case of benign multicystic peritoneal mesothelioma: a clinical dilemma.Academic Article Why?
Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays.Academic Article Why?
Eng, OliverPerson Why?
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.Academic Article Why?
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.Academic Article Why?
Per Page    Page  of 4last Nextnext
Prev
Search Criteria
  • Peritoneal
  • Mesothelioma
Filter by Type